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Abstract
We investigated the application of pulsed laser ablation (PLA) for the production of magnetic
nanoparticles (MNPs)/drug nanocomposites. Magnetic drug delivery vehicles can provide a
multifunctional theranostic platform and allow for a combination of diagnostics, monitoring and
therapeutics. We applied nanosecond laser pulses at two different wavelengths (Nd:YAG laser,
λ1 = 532 nm/λ2 = 1064 nm, FWHM = 6 ns) for the ablation of target tablets consisting of a
mixture of ibuprofen (as a model drug) and magnetite NPs in various mass ratios.
Fourier-transform infrared and Raman spectroscopy investigations of the ablated particles
revealed that PLA induced no chemical changes in the pharmaceutical compound. The size
distributions of the composite particles were established using a particle size analyzer (scanning
mobility particle sizer), and 100–150 nm mean particle size values were obtained. SEM, energy
dispersive x-ray spectroscopy and fast photography studies provided morphological and
compositional information about the ablated particles. We demonstrated that PLA offers a
simple and chemical free method for producing MNPs/drug nanocomposites, and it can be
applied for the future development of new theranostic nanosystems.
Keywords: nanocomposites, drug preformulation, pulsed laser ablation, magnetite nanoparticle,
theranostic, drug delivery
(Some figures may appear in color only in the online journal)
∗
Author to whom any correspondence should be addressed.
Original content from this workmay be used under the terms
of the Creative Commons Attribution 4.0 licence. Any fur-
ther distribution of this work must maintain attribution to the author(s) and the
title of the work, journal citation and DOI.
1361-6463/21/395401+11$33.00 1 © 2021 The Author(s). Published by IOP Publishing Ltd Printed in the UK
J. Phys. D: Appl. Phys. 54 (2021) 395401 T Gera et al
1. Introduction
Nanomedicine, an emerging field of medicine, shows
great promise for developing innovative nanotechnological
solutions. With the help of nanocomposites it is now possible
to diagnose and/or treat several diseases at a molecular level
[1]. Magnetosensitive nanocomposites as drug delivery sys-
tems can induce the accumulation and then the release of phar-
maceuticals at specific body sites to improve their therapeutic
effect while minimizing adverse reactions, and in combination
with the MRI technique, the path of nanocomposites can be
traced in the body [2–9].
The core of magnetic drug delivery vehicles is commonly
magnetite (Fe3O4) due to its superparamagnetic properties and
good biocompatibility [10–14]. The applicability of magnetic
nanoparticles (MNPs) in therapy and diagnostics strongly
depends on the particles’ size, shape, surface properties and
terminal functional groups [15]. Thus, the production of drug-
loadedMNPs is of great importance, but it often requires com-
plex and costly technology [16]. Therefore, the search for
novel methods which may simplify the preparation of mag-
netosensitive nanocomposites is still relevant.
Pulsed laser ablation (PLA) is a well-established and effi-
cient method for the nanonization of both organic and inor-
ganic materials. In the course of PLA, a high-energy pulsed
laser beam is focused onto the target. This creates a micro-
explosion at the surface region and particle ejection occurs
[17, 18]. It has already been shown that even drug particles
can be ground by PLA with no chemical decomposition of the
initial compounds [18–22]. Moreover, we previously repor-
ted the successful size reduction of ibuprofen (and other non-
steroidal anti-inflammatory drug (NSAID)) particles with the
same method [23]. In the present experiment we applied PLA
for loading the magnetite NPs with ibuprofen as a model com-
pound. Due to its low solubility, ibuprofen can serve as a func-
tionalization molecule for surface modification or as a linker
for targeted drug delivery.
By the laser ablation of ibuprofen and magnetite NP mix-
tures, we could utilize the size reduction ability of PLA
in combination with the production of composite particles.
The fluence of the Nd:YAG laser system (λ1 = 1064 nm,
λ2 = 532 nm) was adjusted to gain the highest yield of ablated
particles without any chemical decomposition of ibuprofen
[23]. We investigated the chemical composition and the size
distribution of the ablated particles as well as their behavior in
an external magnetic field.
Our motivation was to show that PLA has a favorable and
multifunctional potential in the development of new pharma-
ceutical formulations in terms of both particle size reduction
and the encapsulation of MNPs. Our aim was to produce a
magnetite based nanocomposite in which ibuprofen as amodel
drug is merged with the MNPs. PLA can give a new and
‘green’ approach for the generation of drug loaded magnetic
nanocomposites. Here we present a relatively simple, single-
step approach to provide magnetically responsive nanocom-
posite carrier systems for drugs. Our method could provide
a new approach for the development of drug loading through
direct encapsulation of MNPs and therapeutic agents [24].
Figure 1. Experimental setup for PLA of mixed tablets.
2. Materials
2.1. Ibuprofen
Ibuprofen (α-methyl-4-(isobutyl) phenylacetic acid) was
obtained from Sigma-Aldrich Ltd, (Saint Louis, Missouri,
USA) (⩾98%). It is a white powder with a particle size
of 15.3 µm (d(0.5)). NSAID classification: propionic acid
derivatives. Thermal properties: melting point Tm = 75 ◦C–
77 ◦C; boiling point Tb = 157 ◦C; decomposition temperature
Tdec = 230 ◦C–250 ◦C [25].
2.2. Magnetite nanopowder
Magnetite (Fe3O4) was acquired from Sigma-Aldrich Ltd,
(Saint Louis, Missouri, USA) (⩾97% trace metal basis). It
is a black nanopowder with a particle size of 50–100 nm.
Thermal properties: melting point Tm = 1597 ◦C; boiling point
Tb = 2623 ◦C [26].
3. Experimental methods
3.1. PLA of ibuprofen-magnetite composite tablets
We prepared ibuprofen-magnetite composite tablets with 4:1;
3:1 and 2:1 (ibuprofen:magnetite) mass ratios. The component
powders were mixed and then compacted by a hydraulic com-
pactor at 175 MPa pressure to form the target samples. Dur-
ing the PLA of the tablets we applied two laser wavelengths:
the first and second harmonics of an Nd:YAG laser (Quantel,
FWHM= 6 ns, λ= 532 nm/1064 nm, f = 1 Hz) with a fluence
2
J. Phys. D: Appl. Phys. 54 (2021) 395401 T Gera et al
Figure 2. Pump and probe setup for fast photography
measurements.
Figure 3. FTIR spectra of PLA generated particles collected on the
membrane filters. The laser wavelengths (1064 nm, 532 nm) and the
mass ratios of ibuprofen:magnetite (4–1, 3–1, 2–1) in the targets are
indicated.
of 9 J cm−2. The fluence was carefully selected not to destroy
the target material but still to gain sufficient ablation yield for
analysis [23].
Figure 1 shows our basic experimental setup. The tab-
lets were fixed on a rotating sample holder at the bottom of
the reaction chamber. We focused the laser beam on the tar-
get surface at a grazing angle of 45◦ by an N-BK7 fused
silica plano convex lens (focal length = 17.5 cm). A con-
stant flow of N2 gas (flow rate: 0.3–2 l min−1) through the
chamber provided a non-oxidative environment and directed
the ablated particles towards the outlet. At the outlet, the
particles were either collected on a membrane filter (pore size
∼1 µm, Merck Millipore Ltd Omnipore Membrane Filter) for
chemical analysis, or directed straight into the particle size
analyzer.
3.2. Chemical composition characterization methods
To ensure that the chemical composition of the ablated
products is identical with that of the initial compounds, the
ablated particles were analyzed by Fourier-transform infrared
(FTIR) and Raman spectroscopy.
3.2.1. FTIR spectroscopy. We analyzed the ablated particles
depositing on themembrane filters as well as those which were
directed sideways from the ablation plume by a magnet and
were collected on silicon plates (see figures 1 and 2). Particles
were scraped from the filters/Si plates and mixed with KBr
powder for pellet formation. FTIR spectra were recorded by a
Thermo Nicolet AVATAR 330 Spectrometer (LabX Midland,
ON, Canada) in the 4000–400 cm−1 range, at a resolution of
4 cm−1, using the average of 128 scans.
3.2.2. Raman spectroscopy. Raman spectroscopy meas-
urements were carried out by a Thermo Scientific, DXR
Raman microscope. A laser beam of λ = 532 nm wavelength
and 0.1–2 mW power was used with a 0.7 µm spot size on
the sample. We applied a 50 µm slit spectrograph aperture
and 900 lines mm−1 grating. Raman spectra were recorded in
the 200–1800 cm−1 range with a resolution of 5.4 cm−1. All
spectra were recorded by scanning ten times with a 4 s integ-
ration time. Spectra were recorded from several places of the
samples covering the membrane filters to obtain information
about their heterogeneity.
3.3. Particle size analysis with a scanning mobility particle
sizer (SMPS)
We measured the particle size distribution in the 10–800 nm
range with SMPS (TSI system Model 3938, USA). We set the
scanning time to 5 min and repeated the measurements at least
three times. The gas flow was 0.3 l min−1 during the scans.
Because the tablets wear away during the relatively long scan-
ning time, here we lowered the laser pulse repetition rate to
0.3 Hz during ablation.
3.4. SEM and energy dispersive x-ray spectroscopy (EDX)
The morphology and elemental composition of the ablated
particles were studied by SEM (Hitachi S-4700 FESEM)
coupled with EDX spectroscopy (RÖNTECXFlash Detector).
For SEM and eventual transmission electron spectroscopy
(TEM) analyses, the particles were placed on TEM-grids by
passing the carrier gas stream through the grids at the outlet.
3.5. Fast photography
We set up a common pump and probe system (figure 2) to visu-
ally observe the ablation process and the effect of the magnetic
field on the trajectory of PLA generated particles. The pump
3
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Figure 4. Raman spectra of PLA (λ = 532 nm) generated particles (blue). Ibuprofen:magnetite mass ratios in the blended targets were
(a) 4:1; (b) 3:1 and (c) 2:1. Magnetite (red) and ibuprofen (black) reference spectra are also shown in (a), (b) and (c). Subset (d) shows the
magnetite reference spectrum (red) and the magnetite spectrum obtained by subtraction (see text for details) in case of a blended target
sample with an ibuprofen:magnetite mass ratio of 3:1 (black).
laser was the same Nd:YAG laser (Quantel, FWHM = 6 ns,
λ = 532 nm) as for the PLA experiments. As a probe laser,
we built a nitrogen laser induced dye laser adapted to the
ablating wavelength. The laser active dye was Rhodamine 6G
(λ = 590 nm, FWHM = 1 ns) in order to avoid an over-
lap between the pump and probe signals. The dye laser beam
was transported to the experimental region by an optical fiber
and collimated with an N-BK7 focusing lens ( f = 17.5 cm).
A CCD camera (The Imaging Source-DMK 23G445, 30 fps,
N = 5×) was placed opposite the optical fiber. We applied a
bandpass optical filter in front of the camera to filter out the
white light of the generated plasma. The controlling element
of this setup was the digital delay generator (SRS-DG645),
which can separately trigger the pump and the probe lasers and
the camera with a delay time in the nanosecond to millisecond
range.
4. Results
4.1. FTIR spectroscopy of the PLA generated particles
The FTIR spectra of the particles collected on the mem-
brane filters are shown in figure 3. The characteristic peaks of
ibuprofen (e.g. 1720 cm−1 (H-bonded C=O); 1231 cm−1 (H-
bonded CO–H); 780 cm−1 (C=O)) [27] and magnetite nano-
powder (573 cm−1) [28] can be identified in each spectrum,
indicating that the ablated particles consist of the chemically
unchanged initial compounds. Two peaks between 2250 cm−1
and 2500 cm−1 are related to the H2O and CO2 content of the
samples.
(We note, that any negative peaks in the 2250–2500 cm−1
range are only due to the different water content of the samples
and the clean filter used for background subtraction.)
4.2. Raman spectroscopy of the PLA generated particle
The investigation of the ibuprofen-magnetite composite
particles by Raman spectroscopy was challenging since the
optimal excitation laser power required for spectrum recording
differed significantly for the two compounds.
The Raman spectra of particles produced by PLA at 532 nm
and 1064 nm laser beam wavelengths are shown in figures 4
and 5, respectively. The characteristic ibuprofen peaks (477,
833 and 1608 cm−1) [28] are clearly present in these spec-
tra. However, the identification of magnetite by Raman spec-
troscopy is problematic since magnetite is susceptible to the
photolytic and pyrolytic effects of the excitation laser light,
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Figure 5. Raman spectra of PLA (λ = 1064 nm) generated particles (blue). Ibuprofen:magnetite mass ratios in the blended targets were
(a) 4:1; (b) 3:1 and (c) 2:1. Subset (d) shows the magnetite reference spectrum (red) and magnetite spectrum obtained by subtraction (see
text for details) in case of a blended target sample with an ibuprofen:magnetite mass ratio of 3:1 (black).
Figure 6. Results of the SMPS measurements: (a) size distribution
mode values for various ibuprofen:magnetite ratios; (b) a typical
particle size distribution of ablated particles.
and spectral changes may occur due to sample transformation
while recording the Raman spectrum [29]. Therefore, we
applied the lowest laser powers which still resulted in valuable
spectral details for both components. However, the intensity of
the most prominent magnetite Raman peak (663 cm−1) was an
order of magnitude lower than the intensity of the ibuprofen
peaks. To be able to detect the magnetite content, the refer-
ence spectrum of ibuprofen was subtracted from the spectra
of the composite particles after normalization for the ibupro-
fen peak at 833 cm−1 (figures 4(d) and 5(d)). Even though
these ibuprofen-free spectra (i.e. those corresponding to mag-
netite only) are rather dissimilar, the characteristic magnetite
peak at 633 cm−1 can be identified for all PLA produced
particles.
4.3. Particle size analysis
We investigated the size distribution of the PLA gener-
ated particles in the 10 nm–1 µm size range. The low
laser pulse repetition rate (0.3 Hz) introduces uncertainty
into the measurements since the particles reached the filter
intermittently.
A typical size distribution and the mode values of the
PLA generated particles when 532 nm and 1064 nm laser
wavelengths are used can be seen in figure 6. The mode val-
ues are 90–130 nm for the composite targets, and 80–90 nm
for the pure ibuprofen target, which is in good agreement with
our former observation [23]. Without claiming completeness,
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Figure 7. SEM images of PLA generated particles from (a) pure ibuprofen tablet target; (b) pure magnetite nano-powder target and
(c) composite ibuprofen:magnetite tablet target with a mass ratio of 3:1. Magnification: 50 000×.
Figure 8. PLA generated particles deposited onto Si plate (a) in the absence of a magnetic field (b) in the presence of a magnetic field.
it must be noted that the maximum transportable particle size
is limited by the gas flow rate, which cannot be more than
0.3 l min−1 for SMPS.
4.4. SEM investigation of PLA generated particles
Figure 7 shows the SEM images of ablated pure ibupro-
fen, magnetite and composite particles collected on mem-
brane filters. The magnetite and ibuprofen parts of the
composite particles can be distinguished to some extent
based on their morphological differences. The occur-
rence of larger particles (>150 nm) on the filters as
compared to the particle sizes measured by SMPS (80–
130 nm), can semi-quantitatively be explained by the
higher (2 l min−1) gas flow rate applied during collection,
which has increased the upper size limit of transportable
particles. Moreover, generated particles can condensate on the
filter too.
4.5. Fast photography in the absence and presence of a
magnetic field
We used fast photography to demonstrate the effect of
magnetic field on the ablated products and to verify the
magnetite content of the particles.
Figure 8 shows the particle abundance deposited onto Si
plates placed sideways from the ablation plume and having
(figure 8(b)) or not having (figure 8(a)) a magnet behind. It
can be clearly seen that the number of deposited particles are
magnitudes higher when a magnetic field is applied.
Figure 9 shows that in the absence of a magnetic field the
particles are ejected in the direction normal to the substrate
surface (figure 9(a)). However, the trajectory of the ablated
particles can be significantly modified by a magnet placed
sideways (figure 9(b)). The influence of the magnetic deflect-
ing force is more noticeable in the case of smaller particles,
which could either indicate their higher magnetite mass con-
tent, or it could simply be the consequence of their lower mass
6
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Figure 9. Fast photography images of ejected particles generated by the PLA of ibuprofen-magnetite composite tablets (a) without any
external magnetic field; (b) in the presence of a magnetic field.
Figure 10. FTIR spectra of PLA generated particles collected on
the silicon plate placed sideways (with a magnet behind) at 532 nm
laser wavelength in case of an ibuprofen:magnetite mass ratio of 3:1.
even if they contain the same amount (and up to a point, even
lower amount) of magnetite as the heavier ones.
4.6. Results in the presence of a magnetic field
4.6.1. FTIR spectroscopy. Figure 10 shows the FTIR spec-
trum of particles being collected on the Si plate.We display the
characteristic bands of ibuprofen (e.g. 1720 cm−1 (H-bonded
C=O); 1231 cm−1 (H-bonded CO–H); 780 cm−1 (C=O)) [27]
and magnetite (573 cm−1) [30]. Here we present only one
spectrum of the ablated particles using a composite target with
an ibuprofen:magnetite mass ratio of 3:1. The presence of the
characteristic peaks of both compounds indicates the compos-
ite character of the ablated particles.
4.6.2. SEM and EDX investigation of PLA generated particles.
Figure 11 depicts the SEM image, the elemental composi-
tion map and the EDX spectrum taken from the same particles.
These particles were directed onto the collecting silicon plate
by a magnetic field. The overlapping carbon (C) and iron (Fe)
content of the particles indicates their composite character.
4.6.3. Particle size measurement (SMPS) in the presence of
a magnetic field. We made another modification in our first
experimental setup for particle size measurement. To measure
the size distribution of the magnetite containing (i.e. mag-
netic) particles, we put a y-branch in front of the entrance
of the SMPS. One of the pipes was connected to the particle
sizer (SMPS) and the other pipe was inserted into a vacuum
tube where the gas flow was set to the same rate as that of
the SMPS (0.3 l min−1). With the help of an Nd magnet, the
magnetic particles were guided into the pipe connected to the
SMPS. The size distribution of the deflectedmagnetic particles
is shown in figure 12. Due to the uncertainty in the ablation
yield, we repeated the measurements several times (with and
without using the magnet). In figure 12 we represent the aver-
aged size distribution curves. It can be seen that the detec-
ted portion of the ablation yield grows with magnetic field
assistance.
5. Discussion
In the course of PLA, two main processes must be con-
sidered. At first, the focused laser beam induces a micro-
explosion in the target. The maximum temperature depends
on the optical absorption coefficient (α), the specific heat (c)
and the density (ρ) of the material, as well as on the applied
fluence of the laser beam. At this stage, vaporized and strongly
decomposed products are formed and ejected from the sur-
face. Secondly, the high temperature and pressure conditions
trigger the formation of shock waves and recoil forces in the
bulk. The photomechanical effects eventually induce the ejec-
tion of chemically preserved material. When interpreting the
ablation mechanism of our targets, we must consider the fol-
lowing: (a) our targets are porous, which results in lower tem-
peratures, higher photomechanical effects and higher ablation
yields [23] compared to the bulk materials. (b) The targets are
7
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Figure 11. (A) SEM image of ablated particles being collected on a Si plate by a magnetic field. The ibuprofen: magnetite mass ratio in the
target tablet was 3:1, and the applied laser wavelength was λ = 532 nm. (B) EDX element mapping of the same area. The green and red
dots correspond to carbon (C) and iron (Fe) atoms, respectively. (C) EDX spectrum recorded from the same area.
inhomogeneous both in particle size and optical properties as
they are mixtures of two very different materials pressed into
pellets. These composite targets show some similarities with
the matrix-assisted pulsed laser evaporation (MAPLE) targets.
In MAPLE, the solvent absorbs most of the laser energy, evap-
orates and entrains the solute (usually an organic compound)
in intact form. We think that a similar scenario occurs in our
case too [31].
To elucidate the ablationmechanism,wemade approximate
calculations—in accordance with our former study [23]—to
determine the temperature rise in the composite targets and the
penetration depth (d) of the laser beam. For the calculations
we used the physical and thermal properties of bulk ibuprofen
and magnetite, since the initial size of the particles fell in the
500–1000 nm range for ibuprofen and in the 50–100 nm range
for magnetite.We used the Beer–Lambert law (equation (1)) to
calculate the temperature change (caused by optical heating)





where α is the wavelength dependent absorption coeffi-
cient, x is the distance from the surface,F is the applied fluence
of the laser beam, ρ is the density of the target and c is the spe-
cific heat of the target material. Pure ibuprofen has relatively
low optical absorption (α = 2 × 105 m−1) at the applied laser
wavelengths, which causes lower maximum temperatures
(104 K) and larger penetration depths (d = α−1) (3–5 µm)
compared to magnetite. The optical absorption of magnetite is
two orders of magnitude higher (α = 2 × 107 m−1) at both
applied wavelengths [32], which generates higher temperat-
ures (105 K) at the surface, but smaller penetration depths
(50–100 nm). In the bulk not only the optical heating must be
considered, but the heat transfer effects too. For this purpose,






where dQ/dt is the rate of heat transfer, A is the area of
cross-section of the heat flow path, λ is the heat conductivity
of the material, dT/dx is the temperature gradient.
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Figure 12. Particle size distribution of the generated particles using
532 nm laser wavelength and 9 J cm−2 fluence in case of using a
deflecting magnet (black) and without a magnet (red).
We must consider different scenarios, depending on the
uppermost surface structure of the target at the site of the
laser shot. (a) When the laser beam is incident on a relat-
ively large (10–15 µm) ibuprofen particle, most of the laser
energy is absorbed by the ibuprofen, and the adjacent mag-
netite particles remain intact. Here photomechanical effects
induce mainly particle fracturing [23]. (b) When magnetite
NPs, which are approximately equal in size with the penetra-
tion depth, are irradiated directly by the laser beam at the target
surface, the ablation process depends on the depth of embed-
ding of the ibuprofen particles. The SEM images reveal that the
ibuprofen particles are typically surrounded and covered by
some layers of magnetite NPs. First, let us consider a 200 nm
thick magnetite coverage (approximately two layers of NPs)
over the ibuprofen particle. In this case, due to the optical
absorption of magnetite, (using equation (1)), a ∼9 × 103 K
temperature rise at the surface of the embedded ibuprofen
particlemust be taken into account. (The temperature rise from
transmitted laser fluence is by orders of magnitude smaller,
and therefore negligible.) Using an approximate heat conduct-
ivity (λ= 0.1 Wm−2 K−1) for ibuprofen, which can be a good
estimate for an organic compound, we calculated that a relat-
ively thin (∼150 nm) upper layer of ibuprofen decomposes
(Tdec.ibu = 250 ◦C) down to 350 nm under the tablet sur-
face, while it evaporates down to 2.35 µm (Tboil.ibu = 157 ◦C)
and melts down to a depth of 7 µm (Tmelt.ibu = 75 ◦C)
(figure 13(A/I)). The molten or vaporized ibuprofen can con-
dense on the magnetite NPs (figure 13(B)) resulting in the
formations observed by SEM. Now, if we consider that the
laser beam hits a region containing only magnetite adjacent
to the ibuprofen (figure 13(A/II)), then the ablation of the top
300 nmmagnetite layer can be described by the optical absorp-
tion model. This is the depth above which the temperature rise
(due to optical heating) exceeds themelting point ofmagnetite.
Below this depth, heat conduction of solid magnetite is the
main heat transfer mechanism, resulting in elevated temperat-
ures in the target bulk. Calculatingwith the significantly higher
heat conductivity of bulk magnetite (λ = 3.5 Wm−2 K−1)
we obtained that the temperature can exceed Tdec.ibu even at
2.46 µm below the target surface in the region containing only
magnetite. Thus, even those Ibuprofen particles (or particle
parts) which are embedded 2.46 µm deep in the target can
decompose, evaporate or melt due to the heat transfer from the
nearbymagnetite in adjacent regions. Thismeans that themag-
netite particles surrounding the ibuprofen particles provide
additional heat (the intensity of which decreases with depth)
from the lateral side of the ibuprofen particles (figure 13(A)).
We must note that our targets are porous, and the above cal-
culations give a strong upper estimation for the temperat-
ures and characteristic depths of ablation. According to our
SEM–EDX investigations, unmerged magnetite and ibupro-
fen particles are also generated during the ablation. Figure 13
illustrates a schematic approach to particle production, where
composites are formed in a pure core–shell structure. Con-
sidering the chaotic particle motions during ablation, as well
as the sizes and morphologies observed in SEM images, it is
clear that the merged particles have a variety of morpholo-
gies, such asmatrix dispersed, Janus or even inverse core–shell
structure [33].
As can be seen in figure 9, particles with a wide size dis-
tribution are produced during ablation. The biggest and heav-
iest particles immediately fall down before reaching the mem-
brane filter or the entrance of SMPS. According to the FTIR
and Raman spectroscopy investigations (figures 3–5), the gen-
erated particles contain chemically preserved ibuprofen and
magnetite NPs in case of both applied wavelengths. The pres-
ence of intact ibuprofen (showing no sign of molecular decom-
position) indicates that these products must originate from the
secondary, photomechanical ablation process. The results of
particle size analysis (figure 6) are in good agreement with
our former studies [23] and with the initial particle size of
magnetite. We cannot see any clear tendencies in particle size
distributions in terms of wavelengths or different mass ratios
of the constituents. This observation is most likely related to
the porosity of the targets, which leads to uncertainties in the
determination of the ablation yield and the mode values of the
size distributions too. PLA generated pure ibuprofen and pure
magnetite particles look quite different and can easily be dis-
tinguished in the SEM images (figure 7).
While searching for more evidence for the merge of ibupro-
fen and magnetite NPs we also studied the particles behavior
in an external magnetic field. We found that small particles
could be easily diverted by the magnetic field, but larger and
heavier particles simply kept moving in their initial direction
(figure 9). This behavior of the large particles is related to their
lower specificmagnetism as they are typically larger ibuprofen
particles with only a few magnetite NPs stuck to their surface.
EDS analysis of the diverted particles has shown that in addi-
tion to magnetite, these products have a relatively high ibupro-
fen content (figures 10 and 11), which is a further proof of
merging of the two components.
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Figure 13. Schematic layout of (A) laser-irradiated volume of ibuprofen-magnetite tablets; (B) composite nanoparticle evolution during the
explosion of PLA.
6. Conclusion
We have successfully produced ibuprofen-magnetite compos-
ite NPs by PLA. The size of the particles was in the 100–
150 nm range and depended both on the mass ratio of the
ingredients in the target pellet and on the laser wavelength. We
confirmed the magnetite content of the particles and the pre-
served chemical character of the drug constituent. Our simple
model calculations suggest that the high absorption coeffi-
cient of magnetite results in the melting and evaporation of
ibuprofen during ablation, and that the composite particles are
formed by the condensation or merging of ibuprofen on the
surface of magnetite NPs.
PLA can provide a simple and chemical-free method for
making composite NPs from a pharmaceutically active com-
pound and MNPs. This approach can be used for the develop-
ment of new drug formulations, especially for targeted drug
delivery applications.
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